<p>Verteporfin therapy is indicated for the treatment of patients with predominantly classic subfoveal choroidal neovascularization due to&nbsp;age-related macular degeneration, pathologic myopia or presumed&nbsp;ocular&nbsp;histoplasmosis.<br />
<br />
There is insufficient evidence to indicate Verteporfin for the treatment of predominantly occult subfoveal choroidal neovascularization.</p>